Stemline Therapeutics, Inc. (NasdaqCM:STML) is seeking acquisitions. Stemline Therapeutics, Inc. has completed a follow-on equity offering in the amount of $45 million. Stemline said it used the proceeds to evaluate assets in an effort to expand our clinical and preclinical pipeline via strategic acquisitions and licensing.